Skip to content

The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients

The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients: a Single Center Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03736304
Enrollment
4536
Registered
2018-11-09
Start date
2019-08-01
Completion date
2022-01-31
Last updated
2024-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Early Diagnosis, Outcomes

Brief summary

Acute kidney injury (AKI) is a common disease, but diagnosis is usually delayed or missed in hospitalized patients. The automated electronic alert for AKI may help to improve the outcomes of these patients through identifying all cases of AKI early. Therefore, the investigators conduct a randomly controlled study to test whether automated electronic alert for AKI could improve the outcomes of hospitalized patients.

Detailed description

Acute kidney injury (AKI) is a common disease, but diagnosis is usually delayed or missed in hospitalized patients. The automated electronic alert for AKI may help to improve the outcomes of these patients through identifying all cases of AKI early. Therefore, the investigators conduct a randomly controlled study to test whether automated electronic alert for AKI could improve the outcomes of hospitalized patients. The patients were randomly divided into two groups: Usual care : patients will receive standard clinical care by the primary physicians AKI alert : an AKI alert will be sent to the doctor in charge. The team of kidney experts would give a suggestion if the doctor in charge need a renal consultation.

Interventions

DEVICEAKI alert

An AKI alert will send to the doctor in charge. The team of nephrologists would give suggestions if the doctor in charge need a renal consultation.

OTHERUsual care

Patients will receive standard clinical care by the doctor in charge.

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

All study investigators and participants were blinded to patients randomization status.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospitalized adult patients with an Alert for AKI(based on KDIGO guidelines)

Exclusion criteria

* Patients already having eGFR\<15ml/min/1.73m2 or receiving renal replacement therapy for AKI at the time of alert. * Patients already having a AKI before admission.

Design outcomes

Primary

MeasureTime frameDescription
Estimated glomerular filtration rate changed within 7 dayswithin 7 days diagnosed with AKIMedical record

Secondary

MeasureTime frameDescription
30-day mortalitywithin 30 days diagnosed with AKIMedical record
1-year mortalitywithin 1 year diagnosed with AKItelephone follow-up
receiving renal replacement therapy at seventh day7 daysMedical record
receiving renal replacement therapy at 30th day30 daystelephone follow-up
receiving renal replacement therapy at 1 year1 yeartelephone follow-up
seven-day mortalitywithin 7 days diagnosed with AKIMedical record
the rate of stage 3 AKIwithin 7 days diagnosed with AKIMedical record
the rate of AKI recovery at 90 day90 daystelephone follow-up
the rate of timely-recognition of AKI3 daysMedical record
the interventions for AKIwithin 7 days diagnosed with AKIMedical record
Follow-up rate after discharge1 yeartelephone follow-up
the rate of stage 2 AKIwithin 7 days diagnosed with AKIMedical record

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026